FGF19 and hepatocellular carcinoma: Macrotrabecular-massive HCC (MTM-HCC) is a proliferative and highly aggressive phenotype of HCC that is genetically characterized by TP53 mutations and/or FGF19 amplification, accounting for 10–20% of all cases of HCC [67].